Spots Global Cancer Trial Database for pomalidomide (pom)
Every month we try and update this database with for pomalidomide (pom) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma | NCT02616640 | Multiple Myelom... | Durvalumab Pomalidomide Dexamethasone | 18 Years - | Celgene | |
A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma | NCT02616640 | Multiple Myelom... | Durvalumab Pomalidomide Dexamethasone | 18 Years - | Celgene |